- Home
- UAMY vs AMRN Comparison
UAMY vs AMRN Comparison
Compare UAMY & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UAMY
- AMRN
- Stock Information
- Founded
- UAMY 1968
- AMRN 1989
- Country
- UAMY United States
- AMRN Ireland
- Employees
- UAMY N/A
- AMRN N/A
- Industry
- UAMY Metal Fabrications
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- UAMY Industrials
- AMRN Health Care
- Exchange
- UAMY Nasdaq
- AMRN Nasdaq
- Market Cap
- UAMY 251.9M
- AMRN 216.0M
- IPO Year
- UAMY N/A
- AMRN 1993
- Fundamental
- Price
- UAMY $2.74
- AMRN $12.64
- Analyst Decision
- UAMY Strong Buy
- AMRN Strong Sell
- Analyst Count
- UAMY 4
- AMRN 1
- Target Price
- UAMY $3.38
- AMRN $7.00
- AVG Volume (30 Days)
- UAMY 3.6M
- AMRN 98.5K
- Earning Date
- UAMY 08-08-2025
- AMRN 07-30-2025
- Dividend Yield
- UAMY N/A
- AMRN N/A
- EPS Growth
- UAMY N/A
- AMRN N/A
- EPS
- UAMY N/A
- AMRN N/A
- Revenue
- UAMY $18,865,900.00
- AMRN $214,112,000.00
- Revenue This Year
- UAMY $270.45
- AMRN N/A
- Revenue Next Year
- UAMY $104.06
- AMRN $7.88
- P/E Ratio
- UAMY N/A
- AMRN N/A
- Revenue Growth
- UAMY 97.46
- AMRN N/A
- 52 Week Low
- UAMY $0.27
- AMRN $7.08
- 52 Week High
- UAMY $3.86
- AMRN $16.37
- Technical
- Relative Strength Index (RSI)
- UAMY 47.10
- AMRN 63.66
- Support Level
- UAMY $2.71
- AMRN $12.80
- Resistance Level
- UAMY $3.10
- AMRN $14.01
- Average True Range (ATR)
- UAMY 0.30
- AMRN 0.80
- MACD
- UAMY -0.00
- AMRN 0.04
- Stochastic Oscillator
- UAMY 27.43
- AMRN 54.09
About UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has four operating segments: United States Antimony, Mexican antimony, zeolite, and Precious metals. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.